Genmab | GEN - Процентный доход





Процентный доход Изменить Дата
Agios Pharmaceuticals USD 12.41M 959K 2025-12
Almirall EUR 2.71M 580K 2025-12
Amarin USD 3.37M 3.37M 2024-12
argenx SE USD 44.87M 2.17M 2025-12
AstraZeneca USD 73M 62M 2026-03
Bayer EUR 169M 39M 2025-12
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Exelixis USD 16.13M 1.3M 2026-03
Fresenius Medical Care EUR 14.62M 999K 2026-03
Genmab DKK 25M 8M 2025-06
GlaxoSmithKline GBP 22M 96M 2026-03
GN Store Nord DKK -152M 221M 2025-12
GRIFOLS EUR 9.56M 4.5M 2025-06
Hikma Pharmaceutical USD 4M 0 2024-12
Insmed USD 765K 55K 2024-09
Lakefront Biotherapeutics EUR 13.56M 991K 2026-03
Merck EUR 21M 6M 2025-12
Regeneron Pharmaceuticals USD 193.3M 18.2M 2025-12
Sanofi EUR 33M 81M 2025-12